Related Experiment Videos
Prolonged paralysis following mivacurium administration.
1Department of Perioperative Medicine and Intensive Care, Royal Brisbane Hospital, Queensland.
Anaesthesia and Intensive Care
|June 22, 2002
Summary
Prolonged mivacurium paralysis can occur in patients with abnormal plasma cholinesterase levels. Acquired factors like liver disease and malnutrition significantly contribute to extended muscle relaxation.
Area of Science:
- Anesthesiology
- Pharmacology
Background:
- Mivacurium is a non-depolarizing muscle relaxant metabolized by plasma cholinesterases.
- Its action is typically shorter than other agents, lasting 10-15 minutes.
Observation:
- A case of prolonged mivacurium paralysis following day surgery is presented.
- The patient exhibited genetic predisposition to abnormal cholinesterase levels.
Findings:
- Markedly depressed cholinesterase activity suggested acquired causes.
- Liver disease, malnutrition, and anticholinesterase use were identified as significant contributing factors.
Implications:
- Highlights the importance of considering acquired factors in prolonged paralysis.
- Suggests careful patient evaluation for cholinesterase activity before mivacurium administration.
- Informs anesthetic management in patients with potential for prolonged neuromuscular blockade.